2025 Scientific Sessions Agenda

 Thursday, May 29, 2025

3:50 PM - 4:00 PM NLA Welcome and Introduction
4:00 PM - 6:00 PM Opening Session: Beyond Statins: Evolving Therapeutic Options for Dyslipidemia Management Chair: Christie M. Ballantyne, MD, FNLA
Co-Chair: Kaye-Eileen Willard, MD, FNLA
4:00 PM - 4:10 PM Opening Remarks and Pre-Session Assessment
4:10 PM – 4:18 PM PCSK9 Inhibitors: Mechanism, Evidence, and Clinical Considerations. Prof. Kausik Ray, BSc (hons), MBChB, FRCP, MD, MPhil (Cantab)
4:18 PM - 4:26 PM Bempedoic Acid: Unique role in LDL-C Reduction and Potential Applications. Steve Nissen, MD
4:26 PM - 4:34 PM CETP Inhibitors: Current Data, Promise, and Limitations. Ann Marie Navar, MD, PhD
4:34 PM - 4:42 PM Lp(a) Inhibitors: Emerging Therapies Targeting Lp(a) and Associated Outcomes. Marlys Koschinsky, PhD, FNLA
4:42 PM - 4:50 PM APOC3 Inhibitors: Innovations in Triglyceride Management and Cardioprotection. Daniel Gaudet, MD, PhD
4:50 PM - 4:58 PM GLP-1s: Dual Benefits in Dyslipidemia and Cardiometabolic Health. TBD
5:00 PM – 5:15 PM Panel Discussion: Connecting the Dots
5:15 PM – 5:35 PM Audience Q&A
5:35 PM – 5:50 PM Post-test Questions and Interactive Reflection
5:50 PM – 6:00 PM Closing Remarks and Summary
6:00 PM - 7:00 PM Welcome Reception in Exhibit Hall
7:00 PM - 9:00 PM Satellite Symposium 1

 Friday, May 30, 2025

6:45 AM - 8:45 AM

Symposium Symposium: Lowering LDL-C: The Role of Emerging CETP Inhibitors in Reducing Cardiovascular Risk

This is an independent satellite CME/CE symposium held in conjunction with the NLA 2025 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.

8:00 AM - 8:50 AM Breakfast in Exhibit Hall
8:50 AM - 9:00 AM Opening Remarks
9:00 AM - 10:30 AM Session II: Lipoproteins and Apoproteins: From Structure to Function
9:00 – 9:05 AM Pre-Session Assessment
9:05 – 9:25 AM New Model of ApoB Alan Remaley, MD, PhD
Joe Marcotrigiano, PhD
9:25 – 9:45 AM APOC3: Structure, Origin, and Function Daniel Gaudet, MD, PhD
9:45 – 10:05 AM Data on Structure of Lpa Michael Boffa, PhD
10:05 – 10:30 AM Q&A Panel & Post-Session Assessment
10:30 AM - 11:00 AM Abstract Author Q&A in Exhibit Hall
11:00 AM - 11:20 AM Presidential Address
11:20 AM - 12:00 PM W. Virgil Brown Distinguished Achievement Lectureship & Award
12:00 PM - 12:55 PM Expert Theaters
12:00 PM - 1:00 PM Lunch in Exhibit Hall
1:00 PM - 2:30 PM Session III: Incretin Mimetics in Lipid and Cardiometabolic Clinics
1:00 PM – 1:05 PM Pre-Session Assessment
1:05 PM – 1:25 PM Incretin Mimetics: Who is Right for this? TBD
1:25 PM – 1:45 PM Are Incretins a Lipid Rx, Heart Rx, or just a Weight Loss Rx? Jessica Pena, MD, FNLA
1:45 PM – 2:05 PM GLP-1 Medications: Evidence-Based Diet, Physical Activity and Management to Set Patients up for Long-Term Success Katherine Heyman Saunders, MD
2:05 PM – 2:30 PM Q&A Panel & Post-Session Assessment
2:30 PM - 3:00 PM Abstract Author Q&A in Exhibit Hall
  Session IV: Joint Session from the European Atherosclerosis Society and the National Lipid Association
Early, Sustained, and Comprehensive Control of Lipids and Health: From Therapies to Models of Care a Joint Session from the European Atherosclerosis Society and the National Lipid Association
3:00 PM – 3:10 PM Welcome & Session Introduction
3:10 PM – 3:15 PM Pre-Session Assessment
3:15 PM – 3:30 PM LDL-C Reduction Prof. Kausik Ray BSc (hons), MBChB, FRCP, MD, MPhil (Cantab)
3:30 PM – 3:45 PM Remnant Cholesterol and Triglyceride-Rich Lipoproteins Borge Nordestgaard, MD, DMSc
3:45 PM – 4:00 PM Lp(a) Management Christie Ballantyne, MD, FNLA
4:00 PM – 4:15 PM Systems Approaches to Improving Lipid Management Kaye-Eileen Willard, MD, FNLA
4:15 PM – 4:25 PM Q&A Panel & Post-Session Assessment
4:25 PM – 4:30 PM Closing Remarks
4:30 PM - 5:30 PM Session V: NLA Publications
4:30 PM – 4:35 PM Publication Introduction
4:35 PM – 4:40 PM Familial Chylomicronemia Syndrome Zahid Ahmad, MD, FNLA
4:40 PM – 4:50 PM Persistent Chylomicronemia Christie Ballantyne, MD, FNLA
4:50 PM – 5:00 PM Familial Hypercholesterolemia Anne Goldberg, MD, FACP, MNLA
5:00 PM – 5:10 PM LDL-C Management Made Simple Beth Jackson, MSN, ACNS-BC, CLS, FNLA
5:10 PM – 5:20 PM NLA Expert Clinical Review on the Multidisciplinary Team in Clinical Lipidology Mary Katherine Cheeley, PharmD, CLS, FNLA
5:20 PM – 5:30 PM Q&A Panel
5:30 PM - 6:00 PM Session VI: Late Breakers
6:30 PM - 8:30 PM Symposium 3
8:30 PM - 9:30 PM NLA Member Event

 Saturday, May 31, 2025

7:45 AM - 8:40 AM Expert Theaters
8:00 AM - 8:50 AM Breakfast in Exhibit Hall
8:50 AM - 9:00 AM Opening Remarks
9:00 AM - 10:30 AM Session VII: Risk Stratification
9:00 AM – 9:05 AM Pre-Session Assessment
9:05 AM – 9:25 AM Does HDL-C Matter? Anand Rohatgi, MD
9:25 AM – 9:45 AM Imaging- CCTA for Risk Assessment Dinesh Kalra, MD, FNLA
9:45 AM – 10:05 AM Managing Hypertension for ASCVD Prevention Leandro Slipczuk, MD, PhD
10:05 AM – 10:30 AM Q&A Panel & Post-Session Assessment
10:30 AM - 11:00 AM Abstract Author Q&A in Exhibit Hall
11:00 AM - 12:30 PM Session VIII: Lifestyle and Nutrition
11:00 AM – 11:05 AM Pre-Session Assessment
11:05 AM – 11:25 AM Optimal Diet Ada Cuevas, MD, FNLA 
11:25 AM – 11:45 AM How Ultra Processed Food System Causes Cardiometabolic Disease Kevin Hall, PhD
11:45 AM – 12:05 PM Macronutrient Content of the Diet Across the Lifespan – How Important Is It? Alice Lichtenstein, DSc, MS
12:05 PM – 12:30 PM Q&A Panel & Post-Session Assessment
12:30 PM - 1:30 PM Lunch in Exhibit Hall
12:30 PM - 1:30 PM Expert Theaters
1:30 PM - 3:00 PM Session IX: Severe Hypercholesterolemia
1:30 PM – 1:35 PM Pre-Session Assessment
1:35 PM – 1:55 PM Monogenic Familial Hypercholesterolemia; Historical Perspective and Current Directions Maya Safarova, MD, PhD, FNLA
1:55 PM – 2:15 PM Causes of Severe Hypercholesterolemia besides Monogenic FH Dan Soffer, MD, FNLA
2:15 PM – 2:35 PM Ketogenic diet-induced Hypercholesterolemia: Known Unknowns and Unknown Knowns Max Petersen, MD, PhD
2:35 PM – 3:00 PM Q&A Panel & Post-Session Assessment
3:00 PM - 3:30 PM Abstract Author Q&A in Exhibit Hall
3:30 PM - 4:55 PM Session X: Abstract Award Winners
3:30 PM - 4:00 PM NLA Business Meeting and Award Winners
4:00 PM - 4:10 PM Hunninghake Award Winner
4:10 PM - 4:40 PM Poster Presentation Award Winners
4:40 PM - 4:55 PM Q&A Panel
4:55 PM - 6:00 PM Session XI: Young Investigator Award Winners
4:55 PM - 5:45 PM Young Investigator Award Presentations
5:45 PM - 6:00 PM Q&A Panel
6:15 PM - 7:45 PM NLA Honors and Awards Ceremony
7:45 PM - 9:00 PM Foundation of the NLA Event

 Sunday, June 1, 2025

7:30 AM - 8:30 AM NLA Community Service
8:00 AM - 8:50 AM Breakfast
8:50 - 9:00 AM Opening Remarks
9:00 AM - 10:30 AM Session XII: Hypertriglyceridemia
9:00 AM – 9:05 AM Pre-Session Assessment
9:05 AM – 9:25 AM HTG - Different Rx for Different Outcomes Ira Goldberg, MD, FNLA
9:25 AM – 9:45 AM Clinical Aspects of HTG Zahid Ahmad, MD, FNLA
9:45 AM – 10:05 AM The Role and Mechanism of AngPTL3-4 Sander Kersten, PhD
10:05 AM – 10:30 AM Q&A Panel & Post-Session Assessment
10:30 AM - 10:45 AM Break
10:45 AM - 12:15 PM Session XIII: LSP Case Presentations
12:15 PM Adjourn